ArticleFrontiers in immunology2025

Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy.

Lindsay Webb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.